Commerce and industry minister Piyush Goyal on Monday said intellectual property rights (TRIPS) waiver for five years agreed in the recently concluded WTO meet will help developing countries manufacture patented Covid vaccines to deal with the pandemic.
Goyal said that India already has a number of Covid vaccines and can help other developing countries to make vaccines.
Members of the World Trade Organisation (WTO) last week agreed to grant a temporary patent waiver for manufacturing COVID-19 vaccines for five years.
Under this, a country will be able to issue a compulsory licence to its domestic pharma firms to make that vaccine without taking approval from the original maker. Besides, it was also decided to permit export of those vaccines.
However, talks on including therapeutics and diagnostics, as proposed by India and South Africa, under the purview of this waiver would start after six months.
"We have sufficient types of vaccines... So for the current strains of COVID-19, we do not need this TRIPS waiver. We have supported it more for the other developing countries to manufacture vaccines," he told reporters here.
He added that India has also offered to many developing countries that if they want vaccine production in their country, Indian pharma firms are "ready, willing and happy" to support them to set up units.
"In the future, when diagnostics and therapeutics come in (under the patent waiver purview)...we can use this TRIPS waiver to start manufacturing it with their (foreign company having patent) technologies in India," he said.
On agriculture and fisheries subsides, the minister said that India has fully protected the interests of farmers and fishermen.
"We did not come under any pressure..We are known as deal makers and not deal breakers...We stick to our issues...Indian farmers are fully protected," he added.
On agriculture, he said that no questions would be asked on India's public stock holdings, procurement through minimum support price and support given to farmers.
However, several of the issues, including India's demands for finding a permanent solution to the issue of public stock holding for food security purposes and permitting government-to-government sale of food grains from FCI (Food Corporation of India) stocks could not be addressed.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve hit your limit of {{free_limit}} free articles this month, subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Months/month
Smart Essential
₹2,700
1 Year
₹225/Months/month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Unlimited access to all articles
30+ premium stories daily, handpicked by our editor


Complimentary Access to The New York Times
News, Games, Cooking, Audio
Wirecutter & The Athletic
Complimentary Access to Our e-Paper
Digital replica of our daily newspaper
Read, save, share any article


Curated Newsletters on Diverse Topics
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Smart Investment Tips
In-depth stock analysis & insights
The Smart Investor for wealth growth tips


Access to Extensive Historical Archives
Repository of articles and publications dating back to 1997
Ad-free Reading Experience
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Repository of articles and publications dating back to 1997